This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elan Announces The Appointment Of Mr. John Given As General Counsel

Elan Corporation, plc (NYSE:ELN) today announced the appointment of Mr. John Given as General Counsel with effect from 1 March, 2013. Mr. Given will report to the CEO, serve as a member of Elan’s executive management team as well as serve as advisor to the Chairman and the full Board. He will be based in Elan’s Dublin headquarters office.

Mr. Given joins Elan from leading Irish law firm A&L Goodbody, where he was a Senior Corporate Partner. During Mr. Given’s over twenty years in private practice, his clients included many leading Irish and international corporates, including a number in the life sciences sector. Mr. Given has acted as Elan’s lead external counsel for over a decade, advising the company on all of its corporate activity. During his tenure at A&L Goodbody, Mr. Given occupied various leadership positions and was head of the M&A practice for nine years, during which time A&L Goodbody was consistently ranked in international league tables as the number 1 Irish transactional law firm.

Elan’s Chairman, Robert A. Ingram, and CEO, Kelly Martin, commented, “John is a uniquely talented and highly accomplished professional with over 20 years of relevant and in-depth experience in the global arena. His direct M&A expertise and proven track record in both transactions and advisory – serving both international and multi-sector clients - makes him an invaluable addition to our executive team. He is joining us at an exciting time as we advance the company – across multiple dimensions - following the recently announced Tysabri restructuring.”

Messrs. Ingram and Martin concluded, “We have no doubt that the Board, management team, employees, shareholders and industry partners will greatly benefit from John’s exceptional expertise, integrity and leadership. We are enthusiastic to have him join us to work across all aspects of our business”

About Elan

Elan is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. For additional information about Elan, please visit http://www.elan.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs